Enanta Pharmaceuticals
ENTA
#7543
Rank
ยฃ0.30 B
Marketcap
ยฃ10.58
Share price
1.13%
Change (1 day)
180.76%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ0.20 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are ยฃ0.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2025-09-30ยฃ0.20 B-25.84%
2024-09-30ยฃ0.28 B-25.7%
2023-09-30ยฃ0.37 B12.34%
2022-09-30ยฃ0.33 B3.57%
2021-09-30ยฃ0.32 B-13.44%
2020-09-30ยฃ0.37 B-5.58%
2019-09-30ยฃ0.39 B25.46%
2018-09-30ยฃ0.31 B30.29%
2017-09-30ยฃ0.24 B12.36%
2016-09-30ยฃ0.21 B33.41%
2015-09-30ยฃ0.16 B69.7%
2014-09-30ยฃ95.85 M32.64%
2013-09-30ยฃ72.26 M123.39%
2012-09-30ยฃ32.34 M93.6%
2011-09-30ยฃ16.7 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ147.66 B 70,860.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ82.24 B 39,421.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ99.29 B 47,618.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ19.00 B 9,034.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ101.45 B 48,653.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ66.74 B 31,972.58%๐Ÿ‡บ๐Ÿ‡ธ USA